| $337M | ||
| $259M | ||
| $79M | ||
| $60M | ||
| $58M | ||
| $50M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. It also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.
Over the last 12 months, insiders at Delcath Systems, Inc. have bought $0 and sold $0 worth of Delcath Systems, Inc. stock.
On average, over the past 5 years, insiders at Delcath Systems, Inc. have bought $775,922 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 26,882 shares for transaction amount of $100,001 was made by SALAMON STEVEN A J (director) on 2024‑03‑19.
| 2024-03-19 | SALAMON STEVEN A J | director | 26,882 0.106% | $3.72 | $100,001 | +110.63% | ||
| 2024-03-19 | Aharon Gil | director | 26,882 0.106% | $3.72 | $100,001 | +110.63% | ||
| 2023-12-12 | Vukovic Vojo | Chief Medical Officer | 40,000 0.1728% | $3.00 | $120,000 | +140.73% | ||
| 2023-12-08 | MICHEL GERARD J | Chief Executive Officer | 34,000 0.1516% | $2.94 | $99,960 | +150.00% | ||
| 2023-11-17 | Rosalind Advisors, Inc. | director | 100,000 0.6437% | $2.40 | $240,410 | +175.31% | ||
| 2023-11-17 | Pennell Sandra | SVP of Finance, PFO and PAO | 30,000 0.1952% | $2.43 | $72,900 | +175.31% | ||
| 2023-11-16 | Vukovic Vojo | Chief Medical Officer | 60,000 0.3928% | $2.48 | $148,800 | +172.47% | ||
| 2023-11-16 | Hoffman David L. | See Remarks | 40,000 0.2618% | $2.48 | $99,200 | +172.47% | ||
| 2023-10-13 | Purpura John | Chief Operating Officer | 14,505 0.0944% | $3.44 | $49,897 | +44.51% | ||
| 2023-08-21 | Sylvester John Richard | director | 10,550 0.093% | $4.80 | $50,640 | -8.86% | ||
| 2023-03-29 | MICHEL GERARD J | Chief Executive Officer | 19,646 0.0001% | $4.84 | $95,087 | -19.86% | ||
| 2022-12-14 | Rosalind Advisors, Inc. | director | 15,215 0.1678% | $3.62 | $55,045 | +26.22% | ||
| 2022-12-14 | SALAMON STEVEN A J | director | 15,215 0.1678% | $3.62 | $55,045 | +26.22% | ||
| 2022-12-13 | MICHEL GERARD J | Chief Executive Officer | 51,725 0.4573% | $2.90 | $150,003 | +26.22% | ||
| 2022-07-20 | MICHEL GERARD J | Chief Executive Officer | 62,814 0.6782% | $3.98 | $250,000 | +7.50% | ||
| 2022-05-16 | Purpura John | Chief Operating Officer | 3,300 0.0396% | $4.61 | $15,213 | -13.01% | ||
| 2022-05-13 | SALAMON STEVEN A J | 5,000 0.0635% | $5.03 | $25,135 | -15.84% | |||
| 2022-05-12 | SALAMON STEVEN A J | 6,000 0.0764% | $4.90 | $29,424 | -13.19% | |||
| 2022-04-19 | Rosalind Advisors, Inc. | 1,600 0.0191% | $6.25 | $10,000 | -36.05% | |||
| 2022-04-19 | SALAMON STEVEN A J | 1,600 0.0191% | $6.25 | $10,000 | -36.05% |
| SALAMON STEVEN A J | director | 1121025 3.2189% | $17.2M | 14 | 0 | <0.0001% |
| Aharon Gil | director | 1069710 3.0716% | $16.41M | 3 | 0 | +23.8% |
| Rosalind Advisors, Inc. | director | 1038828 2.9829% | $15.94M | 12 | 0 | <0.0001% |
| LADD ROBERT | director | 631294 1.8127% | $9.68M | 48 | 11 | |
| MICHEL GERARD J | Chief Executive Officer | 262345 0.7533% | $4.02M | 11 | 0 | <0.0001% |
| Taglietti Marco | director | 220000 0.6317% | $3.37M | 2 | 0 | |
| Philips Laura A | director | 205299 0.5895% | $3.15M | 8 | 0 | |
| HOBBS EAMONN P | President and CEO | 162000 0.4652% | $2.49M | 2 | 0 | |
| Taney Richard | Chief Executive Officer | 161000 0.4623% | $2.47M | 5 | 0 | |
| HERSCHKOWITZ SAMUEL /FA/ | Chief Operating Officer | 160375 0.4605% | $2.46M | 2 | 10 | |
| Kandarpa Krishna | Exec. V.P., Chief Medical Off. | 150000 0.4307% | $2.3M | 0 | 1 | |
| Koplewicz Harold S | director | 148521 0.4265% | $2.28M | 5 | 0 | |
| CORIGLIANO MARK | director | 141225 0.4055% | $2.17M | 0 | 1 | |
| Vukovic Vojo | Chief Medical Officer | 100000 0.2871% | $1.53M | 2 | 0 | +156.6% |
| WATSON DOUGLAS G | director | 61369 0.1762% | $941,400.46 | 1 | 0 | |
| Miao Graham G | Exec. V.P., CFO | 54000 0.1551% | $828,360.00 | 1 | 0 | |
| Purpura John | Chief Operating Officer | 41526 0.1192% | $637,008.84 | 7 | 0 | <0.0001% |
| Hoffman David L. | See Remarks | 40000 0.1149% | $613,600.00 | 1 | 0 | +172.47% |
| Pennell Sandra | SVP of Finance, PFO and PAO | 30000 0.0861% | $460,200.00 | 1 | 0 | +175.31% |
| LEUNG GABRIEL | director | 15847 0.0455% | $243,092.98 | 1 | 0 | |
| Sylvester John Richard | director | 10550 0.0303% | $161,837.00 | 1 | 0 | <0.0001% |
| Rueckert William Dodge | director | 7926 0.0228% | $121,584.84 | 3 | 0 | |
| Keck Barbra | Chief Financial Officer | 7500 0.0215% | $115,050.00 | 3 | 0 | |
| Simpson Jennifer K. | President & CEO | 7500 0.0215% | $115,050.00 | 3 | 0 | |
| STOLL ROGER G PHD | director | 5901 0.0169% | $90,521.34 | 5 | 0 | |
| KOLY M S /FA/ | President and CEO | 0 0% | $0 | 0 | 2 |
| Increased Positions | 62 | +70.45% | 5M | +36.52% |
| Decreased Positions | 38 | -43.18% | 4M | -26.25% |
| New Positions | 21 | New | 2M | New |
| Sold Out Positions | 12 | Sold Out | 202,156 | Sold Out |
| Total Postitions | 112 | +27.27% | 15M | +10.27% |
| Rosalind Advisors, Inc. | $32,865.00 | 8.03% | 2.65M | 0 | 0% | 2024-12-31 |
| Vivo Capital, Llc | $21,186.00 | 5.18% | 1.71M | +711,574 | +71.37% | 2024-12-31 |
| Aigh Capital Management Llc | $17,179.00 | 4.2% | 1.39M | -397,101 | -22.28% | 2024-12-31 |
| Vanguard Group Inc | $15,187.00 | 3.71% | 1.22M | +114,061 | +10.27% | 2024-12-31 |
| Soleus Capital Management, L.P. | $9,932.00 | 2.43% | 801,000 | +801,000 | New | 2024-12-31 |
| Gilder Gagnon Howe & Co Llc | $7,592.00 | 1.86% | 612,235 | +612,235 | New | 2024-12-31 |
| Susquehanna International Group, Llp | $5,191.00 | 1.27% | 418,609 | +343,194 | +455.07% | 2024-12-31 |
| Millennium Management Llc | $3,902.00 | 0.95% | 314,675 | +109,568 | +53.42% | 2024-12-31 |
| Citadel Advisors Llc | $3,591.00 | 0.88% | 289,601 | +135,640 | +88.1% | 2024-12-31 |
| Geode Capital Management, Llc | $3,583.00 | 0.88% | 288,951 | +37,056 | +14.71% | 2024-12-31 |